Cross Border, Cost Effective Solutions
HIRO offers a unique combination of local expertise and international mindset to deliver cross border, cost effective solutions. With its headquarters in Shanghai and global footprints across Asia-Pacific, US and Europe, HIRO is well positioned to support biotech and pharma looking to conduct global clinical trials.
HiRO delivers accelerated commercialisation pathways to global biotech and pharma. Recognising the need to simplify and accelerate trials, our unique lab-to-patient model strives to offer a more comprehensive range of solutions to better support biotech’s through their entire product journey.
Looking to reduce development timelines, our global model is simple;
- through PharmaSols, leverage the benefits of the AU NZ region for early stage clinical trials to maximise the regions streamlined regulatory pathways and cost-effective start-up timeframes.
- leverage HiROs global reach to provide global support for later phase clinical trials where greater participant populations are required.